Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam

Myoclonus in corticobasal degeneration (CBD) has often been associated with severe and difficult to treat disabilities. Levetiracetam is a new antiepileptic agent with antimyoclonic effects. Herein, we present a 72-year-old woman with clinically probable CBD and with spontaneous rhythmic myoclonus i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jae Wook, Lee, Jae Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051726/
https://www.ncbi.nlm.nih.gov/pubmed/24926409
http://dx.doi.org/10.14802/jmd.14007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051726/
https://www.ncbi.nlm.nih.gov/pubmed/24926409
http://dx.doi.org/10.14802/jmd.14007

Ejemplares similares